Skip to main content
SpringerLink
Log in

Choosing the Optimal Self-Injector Epinephrine

  • Anaphylaxis (M Sánchez-Borges, Section Editor)
  • Published:
Current Treatment Options in Allergy Aims and scope Submit manuscript

Abstract

Purpose of review

Anaphylaxis is an acute, systemic, life-threatening allergic reaction, and its choice treatment is epinephrine. Epinephrine may be administered by several routes, but intramuscular is the preferred one because of its fast time of action, as well as easy access. Several devices are commercially available for self-administration, with some differences between them. There are concerns about defects or errors in administration when using autoinjectors.

Recent findings

The main factors that determine the correct use of an autoinjector are the length of needle, body mass index, use of clothing, type of device, and training of the person applying epinephrine. Comparing different devices not only highlights some differences between them; but it also finds the similarities in their effectiveness and defects. There are areas of opportunity in the design and route of administration that may be addressed in future research.

Summary

This review focuses on devices for treatment of anaphylaxis like autoinjectors and includes analysis of factors specific to the device, as well as those dependent on the patient and who applies the device. The best device will be the one that is available, together with adequate training of patient/caregiver and health personnel for its correct use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Shaker MS, Wallace DV, Golden DBK, Oppenheimer J, Bernstein JA, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and grading of recommendations, assessment, development and evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020;145(4):1082–123. https://doi.org/10.1016/j.jaci.2020.01.017 This paper reviews the latest pieces of evidence on anaphylaxis.

    Article  CAS  PubMed  Google Scholar 

  2. Grabenhenrich LB, Dölle S, Ruëff F, Renaudin JM, Scherer K, et al. Epinephrine in severe allergic reactions: the European Anaphylaxis Register. J Allergy Clin Immunol Pract. 2018;6(6):1898–1906.e1. https://doi.org/10.1016/j.jaip.2018.02.026.

    Article  PubMed  Google Scholar 

  3. Robinson M, Greenhawt M, Stukus DR. Factors associated with epinephrine administration for anaphylaxis in children before arrival to the emergency department. Ann Allergy Asthma Immunol. 2017;119(2):164–9. https://doi.org/10.1016/j.anai.2017.06.001.

    Article  PubMed  Google Scholar 

  4. Dubus JC, Lê MS, Vitte J, Minodier P, Boutin A, Carsin A, et al. Use of epinephrine in emergency department depends on anaphylaxis severity in children. Eur J Pediatr. 2019;178(1):69–75. https://doi.org/10.1007/s00431-018-3246-3.

    Article  PubMed  Google Scholar 

  5. Kawano T, Scheuermeyer FX, Stenstrom R, Rowe BH, Grafstein E, Grunau B. Epinephrine use in older patients with anaphylaxis: clinical outcomes and cardiovascular complications. Resuscitation. 2017;112:53–8. https://doi.org/10.1016/j.resuscitation.2016.12.020.

    Article  PubMed  Google Scholar 

  6. Liu X, Lee S, Lohse CM, Hardy CT, Campbell RL. Biphasic reactions in emergency department anaphylaxis patients: a prospective cohort study. J Allergy Clin Immunol Pract. 2020;8(4):1230–8. https://doi.org/10.1016/j.jaip.2019.10.027.

    Article  PubMed  Google Scholar 

  7. • Brown JC, Simons E, Rudders SA. Epinephrine in the Management of Anaphylaxis. J Allergy Clin Immunol Pract. 2020;8(4):1186–95. https://doi.org/10.1016/j.jaip.2019.12.015 This is a very good review on epinephrine.

    Article  PubMed  Google Scholar 

  8. Worm M, Nguyen D, Rackley R, Muraro A, Du Toit G, et al. Epinephrine delivery via EpiPen® auto-injector or manual syringe across participants with a wide range of skin-to-muscle distances. Clin Transl Allergy. 2020;10:21. https://doi.org/10.1186/s13601-020-00326-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Duvauchelle T, Robert P, Donazzolo Y, Loyau S, Orlandini B, Lehert P, et al. Bioavailability and cardiovascular effects of adrenaline administered by Anapen autoinjector in healthy volunteers. J Allergy Clin Immunol Pract. 2018;6(4):1257–63. https://doi.org/10.1016/j.jaip.2017.09.021.

    Article  PubMed  Google Scholar 

  10. Maa T, Scherzer DJ, Harwayne-Gidansky I, Capua T, Kessler DO, et al. Prevalence of Errors in Anaphylaxis in Kids (PEAK): a multicenter simulation-based study. J Allergy Clin Immunol Pract. 2020;8(4):1239–1246.e3. https://doi.org/10.1016/j.jaip.2019.11.013.

    Article  PubMed  Google Scholar 

  11. Waserman S, Avilla E, Harada L, Huang J, Kastner M. Decades of poor availability of epinephrine autoinjectors: global problems in need of global solutions. Ann Allergy Asthma Immunol. 2020;124(2):205–207.e1. https://doi.org/10.1016/j.anai.2019.11.009.

    Article  PubMed  Google Scholar 

  12. Dreborg S, Kim L, Tsai G, Kim H. Epinephrine auto-injector needle lengths: can both subcutaneous and periosteal/intraosseous injection be avoided? Ann Allergy Asthma Immunol. 2018;120(6):648–653.e1. https://doi.org/10.1016/j.anai.2018.02.028.

    Article  PubMed  Google Scholar 

  13. Dreborg S, Tsai G, Kim H. Implications of variation of epinephrine auto-injector needle length. Ann Allergy Asthma Immunol. 2019;123(1):89–94. https://doi.org/10.1016/j.anai.2019.04.027.

    Article  PubMed  Google Scholar 

  14. Moss J, Jani Y, Edwards B, Tomlin S, Rashed AN. Pharmacokinetic and pharmacodynamic evidence of adrenaline administered via auto-injector for anaphylactic reactions: a review of literature. Br J Clin Pharmacol. 2020. https://doi.org/10.1111/bcp.14438.

  15. • Hill RL, Wilmot JG, Belluscio BA, Cleary K, Lindisch D, Tucker R, et al. Comparison of drug delivery with autoinjector versus manual prefilled syringe and between three different autoinjector devices administered in pig thigh. Med Devices (Auckl). 2016;9:257–66. https://doi.org/10.2147/MDER.S83406 This paper is very useful because it compares various types of devices.

    Article  Google Scholar 

  16. Song TT, Lieberman P. Epinephrine auto-injector needle length: what is the ideal length? Curr Opin Allergy Clin Immunol. 2016;16(4):361–5. https://doi.org/10.1097/ACI.0000000000000283.

    Article  CAS  PubMed  Google Scholar 

  17. Kim H, Dinakar C, McInnis P, Rudin D, Benain X, Daley W, et al. Inadequacy of current pediatric epinephrine autoinjector needle length for use in infants and toddlers. Ann Allergy Asthma Immunol. 2017;118(6):719–725.e1. https://doi.org/10.1016/j.anai.2017.03.017.

    Article  PubMed  Google Scholar 

  18. Duong M, Botchway A, Dela Cruz J, Austin R, McDaniel K, Jaeger C. Skin to intramuscular compartment thigh measurement by ultrasound in pediatric population. West J Emerg Med. 2017;18(3):479–86. https://doi.org/10.5811/westjem.2016.12.32279.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Manuyakorn W, Bamrungchaowkasem B, Ruangwattanapaisarn N, Kamchaisatian W, Benjaponpitak S. Optimal needle length for epinephrine prefilled syringe in children. Ann Allergy Asthma Immunol. 2017;118(6):740–741.e1. https://doi.org/10.1016/j.anai.2017.04.005.

    Article  CAS  PubMed  Google Scholar 

  20. Campbell RL, Bellolio MF, Motosue MS, Sunga KL, Lohse CM, Rudis MI. Autoinjectors preferred for intramuscular epinephrine in anaphylaxis and allergic reactions. West J Emerg Med. 2016;17(6):775–82. https://doi.org/10.5811/westjem.2016.8.30505.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Lyng JW, White CC 4th, Peterson TQ, Lako-Adamson H, Goodloe JM, et al. Non-auto-injector epinephrine administration by basic life support providers: a literature review and consensus process. Prehosp Emerg Care. 2019;23(6):855–61. https://doi.org/10.1080/10903127.2019.1595235.

    Article  PubMed  Google Scholar 

  22. Chime NO, Riese VG, Scherzer DJ, Perretta JS, McNamara L, Rosen MA. Hunt EA; International Network for Simulation-based Pediatric Innovation, Research and Education (INSPIRE) collaborative. Epinephrine auto-injector versus drawn up epinephrine for anaphylaxis management: a scoping review. Pediatr Crit Care Med. 2017;18(8):764–9. https://doi.org/10.1097/PCC.0000000000001197.

    Article  PubMed  Google Scholar 

  23. Moss RB, Daniels K, Moll T, Carlo DJ. Human factors study in untrained adolescents comparing a recently approved single-dose epinephrine prefilled syringe with an approved autoinjector. Ann Allergy Asthma Immunol. 2018;120(5):540–1. https://doi.org/10.1016/j.anai.2018.02.027.

    Article  PubMed  Google Scholar 

  24. Pepper AN, Westermann-Clark E, Lockey RF. The high cost of epinephrine autoinjectors and possible alternatives. J Allergy Clin Immunol Pract. 2017;5(3):665–668.e1. https://doi.org/10.1016/j.jaip.2016.12.018.

    Article  PubMed  Google Scholar 

  25. Sargel CL, Maa T. Epinephrine auto-injectors versus manually drawn up epinephrine: is there a better option? Pediatr Crit Care Med. 2017;18(8):807–8. https://doi.org/10.1097/PCC.0000000000001211.

    Article  PubMed  Google Scholar 

  26. Rachid O, Simons FE, Rawas-Qalaji M, Lewis S, Simons KJ. Epinephrine doses delivered from auto-injectors stored at excessively high temperatures. Drug Dev Ind Pharm. 2016;42(1):131–5. https://doi.org/10.3109/03639045.2015.1035283.

    Article  CAS  PubMed  Google Scholar 

  27. Posner LS, Camargo CA Jr. Update on the usage and safety of epinephrine auto-injectors, 2017. Drug Healthc Patient Saf. 2017;9:9–18. https://doi.org/10.2147/DHPS.S121733.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Cantrell FL. Epinephrine concentrations in EpiPens after the expiration date. Ann Intern Med. 2018;168(1):82. https://doi.org/10.7326/L17-0496.

    Article  PubMed  Google Scholar 

  29. Umasunthar T, Procktor A, Hodes M, Smith JG, Gore C, Cox HE, et al. Patients' ability to treat anaphylaxis using adrenaline autoinjectors: a randomized controlled trial. Allergy. 2015;70(7):855–63. https://doi.org/10.1111/all.12628.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Cohen MB, Saunders SS, Wise SK, Nassif S, Platt MP. Pitfalls in the use of epinephrine for anaphylaxis: patient and provider opportunities for improvement. Int Forum Allergy Rhinol. 2017;7(3):276–86. https://doi.org/10.1002/alr.21884.

    Article  PubMed  Google Scholar 

  31. Vale S, Netting MJ, Ford LS, Tyquin B, McWilliam V, Campbell DE. Anaphylaxis management in Australian schools: review of guidelines and adrenaline autoinjector use. J Paediatr Child Health. 2019;55(2):143–51. https://doi.org/10.1111/jpc.14307.

    Article  PubMed  Google Scholar 

  32. Topal E, Karagöl HİE, Yılmaz Ö, Arga M, Köksal B, et al. Comparison of practical application steps of the previously used adrenaline auto injector in Turkey (EpiPen) and the currently available adrenaline auto injector (Penepin): a multi-center study. Turk Pediatri Ars. 2018;53(3):149–54. https://doi.org/10.5152/TurkPediatriArs.2018.6734.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Sirin Kose S, Asilsoy S, Tezcan D, Al S, Atay O, Kangalli O, et al. Is there an optimal training interval to improve the correct use of adrenaline auto-injectors? Int Arch Allergy Immunol. 2020;181(2):136–40. https://doi.org/10.1159/000504365.

    Article  CAS  PubMed  Google Scholar 

  34. Robinson MN, Dharmage SC, Tang ML. Comparison of adrenaline auto-injector devices: ease of use and ability to recall use. Pediatr Allergy Immunol. 2014;25(5):462–7. https://doi.org/10.1111/pai.12261.

    Article  CAS  PubMed  Google Scholar 

  35. • El Turki A, Smith H, Llewellyn C, Jones CJ. A systematic review of patients', parents' and healthcare professionals’ adrenaline auto-injector administration techniques. Emerg Med J. 2017;34(6):403–16. https://doi.org/10.1136/emermed-2016-205742 This is a very interesting systematic review on techniques in epinephrine autoinjectors.

    Article  PubMed  Google Scholar 

  36. Saleh-Langenberg J, de Vries S, Bak E, Kollen BJ, Flokstra-de Blok BMJ, Dubois AEJ. Incomplete and incorrect epinephrine auto-injector training to food-allergic patients by pharmacists in the Netherlands. Pediatr Allergy Immunol. 2017;28(3):238–44. https://doi.org/10.1111/pai.12688.

    Article  CAS  PubMed  Google Scholar 

  37. Worm M, Molaie N, Dölle S. Level of knowledge among pharmacists regarding anaphylaxis and the use of epinephrine autoinjectors. J Dtsch Dermatol Ges. 2018;16(11):1315–21. https://doi.org/10.1111/ddg.13679.

    Article  PubMed  Google Scholar 

  38. Pitsios C, Vasiliadis A, Karakatsanis KP, Matzaras R, Minasidis T, Nteveros A, et al. Availability of epinephrine auto-injectors and knowledge of community pharmacists about their use. Eur Ann Allergy Clin Immunol. 2019;51(5):234–6. https://doi.org/10.23822/EurAnnACI.1764-1489.106.

    Article  CAS  PubMed  Google Scholar 

  39. • Greenberger PA, Wallace DV, Lieberman PL, Gregory SM. Contemporary issues in anaphylaxis and the evolution of epinephrine autoinjectors: what will the future bring? Ann Allergy Asthma Immunol. 2017;119(4):333–8. https://doi.org/10.1016/j.anai.2017.07.030 This is a very interesting article on the history of epinephrine autoinjector devices.

    Article  CAS  PubMed  Google Scholar 

  40. Sánchez-Borges M, Cardona V, Worm M, Lockey RF, Sheikh A, Greenberger PA, et al. WAO Anaphylaxis Committee. In-flight allergic emergencies. World Allergy Organ J. 2017;10(1):15. https://doi.org/10.1186/s40413-017-0148-1.

    Article  PubMed  PubMed Central  Google Scholar 

  41. O'Connor M, Winders T, Meadows JA. Epinephrine autoinjectors on airplanes. Ann Allergy Asthma Immunol. 2020;125(3):250–1. https://doi.org/10.1016/j.anai.2020.06.021.

    Article  PubMed  Google Scholar 

  42. Fromer L. Prevention of anaphylaxis: the role of the epinephrine auto-injector. Am J Med. 2016;129(12):1244–50. https://doi.org/10.1016/j.amjmed.2016.07.018.

    Article  PubMed  Google Scholar 

  43. Portnoy J, Wade RL, Kessler C. Patient carrying time, confidence, and training with epinephrine autoinjectors: the RACE survey. J Allergy Clin Immunol Pract. 2019;7(7):2252–61. https://doi.org/10.1016/j.jaip.2019.03.021.

    Article  PubMed  Google Scholar 

  44. Kessler C, Edwards E, Dissinger E, Sye S, Visich T, Grant E. Usability and preference of epinephrine auto-injectors: Auvi-Q and EpiPen Jr. Ann Allergy Asthma Immunol. 2019;123(3):256–62. https://doi.org/10.1016/j.anai.2019.06.005.

    Article  PubMed  Google Scholar 

  45. Tuttle R, Popescu L, Hill S, et al. Intranasal epinephrine effects on epinephrine pharmacokinetics and heart rate in a nasal congestion canine model. Respir Res. 2020;21(1):78.Published 2020 Apr 3. https://doi.org/10.1186/s12931-020-01343-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Dretchen KL, Mesa Z, Robben M, Slade D, Hill S, Forsee K, et al. Effects of intranasal epinephrine on cerebrospinal fluid epinephrine pharmacokinetics, nasal mucosa, plasma epinephrine pharmacokinetics, and cardiovascular changes. Pharm Res. 2020;37:103. https://doi.org/10.1007/s11095-020-02829-5.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Regional Center for Allergy and Clinical Immunology, Autonomous University of Nuevo Leon, University Hospital, Monterrey, Mexico

    Alejandra Macías-Weinmann MD, Sandra Nora González-Díaz MD, PhD, José Ignacio Canseco-Villarreal MD & Rosa I. Guzmán-Avilán MD

  2. School of Medicine, Autonomous University of Nuevo Leon, Monterrey, Mexico

    Valeria González MS & Andrés Noyola MS

Authors
  1. Alejandra Macías-Weinmann MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sandra Nora González-Díaz MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. José Ignacio Canseco-Villarreal MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rosa I. Guzmán-Avilán MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Valeria González MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Andrés Noyola MS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alejandra Macías-Weinmann MD.

Ethics declarations

Conflict of interest

Alejandra Macías-Weinmann declares that she has no conflict of interest. Sandra Nora González-Díaz declares that she has no conflict of interest. José Ignacio Canseco-Villarreal declares that he has no conflict of interest. Rosa I Guzmán-Avilán declares that she has no conflict of interest. Valeria González declares that she has no conflict of interest. Andrés Noyola declares that he has no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Anaphylaxis

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Macías-Weinmann, A., González-Díaz, S.N., Canseco-Villarreal, J.I. et al. Choosing the Optimal Self-Injector Epinephrine. Curr Treat Options Allergy 8, 1–8 (2021). https://doi.org/10.1007/s40521-020-00276-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40521-020-00276-6

Keywords

Search

Navigation